Participants were randomly assigned (1:1:1) to receive subcutaneous injections of taspoglutide 10 mg weekly, taspoglutide 10 mg weekly for the initial 4 weeks followed by 20 mg weekly, or ...
Roche Holding AG (ROG.VX) said Thursday its experimental diabetes drug taspoglutide worked better than a rival drug sold by Eli Lilly & Co. (LLY) in lowering blood sugar, according to the results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback